1. Home
  2. ICCC vs ONEG Comparison

ICCC vs ONEG Comparison

Compare ICCC & ONEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCC
  • ONEG
  • Stock Information
  • Founded
  • ICCC 1982
  • ONEG 2021
  • Country
  • ICCC United States
  • ONEG Hong Kong
  • Employees
  • ICCC N/A
  • ONEG N/A
  • Industry
  • ICCC Biotechnology: Pharmaceutical Preparations
  • ONEG Homebuilding
  • Sector
  • ICCC Health Care
  • ONEG Consumer Discretionary
  • Exchange
  • ICCC Nasdaq
  • ONEG Nasdaq
  • Market Cap
  • ICCC 39.2M
  • ONEG 38.2M
  • IPO Year
  • ICCC 1987
  • ONEG 2024
  • Fundamental
  • Price
  • ICCC $4.94
  • ONEG $2.40
  • Analyst Decision
  • ICCC
  • ONEG
  • Analyst Count
  • ICCC 0
  • ONEG 0
  • Target Price
  • ICCC N/A
  • ONEG N/A
  • AVG Volume (30 Days)
  • ICCC 10.9K
  • ONEG 24.6K
  • Earning Date
  • ICCC 05-13-2025
  • ONEG 01-01-0001
  • Dividend Yield
  • ICCC N/A
  • ONEG N/A
  • EPS Growth
  • ICCC N/A
  • ONEG N/A
  • EPS
  • ICCC N/A
  • ONEG 0.16
  • Revenue
  • ICCC $26,493,000.00
  • ONEG $63,463,000.00
  • Revenue This Year
  • ICCC N/A
  • ONEG N/A
  • Revenue Next Year
  • ICCC N/A
  • ONEG N/A
  • P/E Ratio
  • ICCC N/A
  • ONEG $20.22
  • Revenue Growth
  • ICCC 51.63
  • ONEG 16.46
  • 52 Week Low
  • ICCC $3.34
  • ONEG $1.96
  • 52 Week High
  • ICCC $5.82
  • ONEG $4.05
  • Technical
  • Relative Strength Index (RSI)
  • ICCC 48.48
  • ONEG N/A
  • Support Level
  • ICCC $4.56
  • ONEG N/A
  • Resistance Level
  • ICCC $5.05
  • ONEG N/A
  • Average True Range (ATR)
  • ICCC 0.23
  • ONEG 0.00
  • MACD
  • ICCC 0.01
  • ONEG 0.00
  • Stochastic Oscillator
  • ICCC 80.51
  • ONEG 0.00

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About ONEG OneConstruction Group Limited Ordinary Shares

OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. It is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction project include performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.

Share on Social Networks: